[VETOQUINOL] H1 2019 RESULTS

Cash flow statement taking into account IFRS 16 2019 H1 Results 13 €m 6/30/2019 12/31/2018* 6/30/2018* Net income - Group share 12.9 36.3 15.8 Free cash flow before net cost of debt and tax 26.6 66.2 27.3 Cash flow from operating activities 5.2 42.7 5.9 Cash flow used by investing activities (59.4) (20.7) (4.4) Cash flow used by financing activities (13.4) (17.0) (10.1) Change in cash and cash equivalents (68.1) 4.6 (9.1) * Restated for the impact of the application of the IFRS 16 standard